COMMUNIQUÉS West-GlobeNewswire

FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
01/07/2026
Novel allogeneic T-cell-based immunotherapy reduces chronic graft-versus-host disease (GVHD) in patients with blood cancers undergoing stem cell transplantation Silver Spring, MD, July 01, 2026 (GLOBE NEWSWIRE) -- The U [...]
Compass Health recognized as a Quasquicentennial Corporation, marking 125 Years of service in Northwest Washington
01/07/2026
As America celebrates 250 years, the community behavioral health nonprofit has operated for half of the nation’s existence EVERETT, Wash., July 01, 2026 (GLOBE NEWSWIRE) -- Compass Health is proud to announce its [...]
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01/07/2026
FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with Tegoprubart ZURICH, July 01, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative [...]
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform
01/07/2026
Commercial Launch Begins Company's First Consumer Revenue Stream, Bringing Science-Backed Women's Health Solutions Directly to Consumers SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE [...]
Managing Mental Health During the Summer
01/07/2026
Park Mental Health experts share strategies for how to protect mental, emotional wellness and manage the busy season San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Summer is officially here and families are busy [...]
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
01/07/2026
SEATTLE, July 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced a symposium presentation highlighting [...]
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
01/07/2026
SCOTTSDALE, Ariz., July 01, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced an [...]
Abivax announces trading resumption of its ordinary shares on Euronext Paris
01/07/2026
Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 1, 2026 – 02:50 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“ Abivax ” or the “ Company ”), a clinical- [...]
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
01/07/2026
Chassieu, 01 juill. 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB) , greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur l’exploitation brevetée d’amibes [...]
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
01/07/2026
SkinTE ® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved. SkinTE ® is a first-in-class autologous cutaneous [...]
LiveWorld Names Rob Thomas Vice President, Creative Director to Support Growing Healthcare Creative Practice
01/07/2026
Veteran healthcare creative leader brings deep pharmaceutical expertise and AI-driven innovation to expand agency capabilities CAMPBELL, Calif. and NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC [...]
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
01/07/2026
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris PARIS, France, 1 er juillet 2026 – 14h35 CEST – Abivax SA (Euronext Paris : FR0012333284 – ABVX) (« Abivax » ou la « Société »), [...]
JenaValve Recaps Key Highlights Including Late-Breaking Clinical Data from New York Valves 2026
01/07/2026
New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy ® System in Patients with Left [...]
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
01/07/2026
Issued 4,444,445 new ordinary shares Priced at €2.70 per share, representing a 14.15% discount on the five-day VWAP and a 12.68% discount to the June 30 closing price The transaction has been structured as a capital [...]
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
01/07/2026
CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2, [...]
Safe Legal Steroid Alternatives: CrazyBulk Announces 2026 Legal Steroids For Muscle Growth and Strength Available In USA
01/07/2026
Discover CrazyBulk's safe legal steroid alternatives designed to support muscle growth, bulking, cutting, strength, and bodybuilding with science-inspired formulas. New York City, July 01, 2026 (GLOBE NEWSWIRE) -- In [...]
How Meaningful Work Supports Long-Term Sobriety
01/07/2026
San Diego-based Shoreline Recovery Center highlights the role employment plays in rebuilding confidence, purpose and stability following addiction treatment San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- For many [...]
Amoéba has received marketing authorization in France for its biofungicide AXPERA
01/07/2026
Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB) , industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained marketing [...]
Medline to report second quarter 2026 results on August 5, 2026
01/07/2026
NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report second quarter 2026 financial results on Wednesday, August 5, 2026. A press release and [...]

Pages